Feb 4 (Reuters) - INDIA'S JUBILANT PHARMOVA:
* DEC-QUARTER CONSOL NET PROFIT 509.9 MILLION RUPEES VERSUS
PROFIT 3.1 BILLION RUPEES YEAR AGO
* JUBILANT PHARMOVA DEC-QUARTER CONSOL SALES 12.98 BILLION
RUPEES
VERSUS 17.44 BILLION RUPEES YEAR AGO
* JUBILANT PHARMOVA - EXPECT CDMO SEGMENT TO WITNESS NEAR
TERM
CORRECTION AS COVID RELATED PRODUCT DEMAND HAS SUBSIDED
* JUBILANT PHARMOVA - PERFORMANCE OF API BUSINESS EXPECTED
TO
NORMALIZE IN Q4 FY22
* JUBILANT PHARMOVA - EXPECT TO INCUR CAPEX OF AROUND 5
BILLION
RUPEES IN FY22
Source text for Eikon: ID:nBSE5P9kH1
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))